Posttransplantation lymphoproliferative disorders treated with cyclophosphamide-doxorubicin-vincristine-prednisone chemotherapy
T. J. Garrett(NewYork–Presbyterian Hospital), Robert E. Michler(Albert Einstein College of Medicine), Eric A. Rose(Icahn School of Medicine at Mount Sinai), Amy Chadburn(Cornell University), Mark L. Barr(University of Southern California), Jonathan M. Chen(Seattle Children's Hospital), Ronald Drusin(NewYork–Presbyterian Hospital), Craig R. Smith(University of Arizona), Larry L. Schulman(NewYork–Presbyterian Hospital), Daniel M. Knowles(Cornell University), Dennis S. Reison(NewYork–Presbyterian Hospital)
Cited by 77
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k
Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients
|New England Journal of Medicine|2019|4.8k
EuroSCORE II
|European Journal of Cardio-Thoracic Surgery|2012|2.9k